SC
WINT

Searle & Co’s Windtree Therapeutics Inc WINT Stock Holding History

Searle & Co’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,893
Closed -$29K – 115
2015
Q4 		$29K Hold
9,893
– – 0.03% 110
2015
Q3 		$42K Hold
9,893
– – 0.04% 103
2015
Q2 		$94K Hold
9,893
– – 0.08% 136
2015
Q1 		$164K Sell
9,893
-714
-7% -$14.1K 0.14% 105
2014
Q4 		$172K Buy
+10,607
New +$233K 0.15% 115

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Searle & Co's WINT Position: Q1 2016 in Review

Searle & Co sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 9,893 shares — an estimated $29K sold.

Searle & Co first reported a position in WINT in Q4 2014 and held it in 5 quarters. The position peaked at $172K in Q4 2014. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Searle & Co reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Searle & Co sold 9,893 Windtree Therapeutics Inc shares in Q1 2016, an estimated $29K.
  • Searle & Co first reported a position in Windtree Therapeutics Inc in Q4 2014 and held it in 5 quarters.
  • Searle & Co's Windtree Therapeutics Inc position peaked at $172K in Q4 2014.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Searle & Co's 13F filing for Q1 2016, filed 12 Apr 2016.